(52.1) Total loans purchased of receivables and accrued interest receivables 80,959 83,622 87,733 8.4 4.9 Less Allowance for expected credit losses (6,476) (6,247) (9,718) 50.1 55.6 Total loans purchased
1,379 660 24.1 (52.1) Total loans purchased of receivables and accrued interest receivables 80,959 83,622 87,733 8.4 4.9 Less Allowance for expected credit losses (6,476) (6,247) (9,718) 50.1 55.6 Total
Management Public Company Limited 2.3 Vintage Analysis The company maintains a portfolio of loans purchased and properties for sale acquired at various points in time. 2.3.1 Loans purchased and Foreclosed
Analysis We maintain a portfolio of credit for the purchase of receivables and properties for sale acquired at various points in time 4.4.1 Loans Purchased and Foreclosed Collateral Properties The following
128.97% For example, from the portfolios of loans purchased that have been acquired in the 1 to 2 years prior to 30 September, 2019 of Baht 13,997.3 million, the Company collected Baht 1,311.2 million (of
factory and machinery around 20 million Baht which totaling the investment of 315 million Baht and can be summarized as follows: Securities to be purchased Ordinary shares of Modern Pharma Company Limited
์(Issuer) varchar(3) Y ชดุ code ทีก่ าหนด (รหสักลุม่เศรษฐกจิ) 7 Beginning Unit จ านวนหน่วยยกมา (หน่วย) Decimal(23,5) 8 Beginning Value มลูคา่ยกมา (บาท) Decimal(23,5) Y 9 Purchased Unit จ านวนหน่วยซือ้หรอื
Purchased Unit จ านวนหน่วยซือ้หรอืเพิม่ (หน่วย) Decimal(23,5) 10 Purchased Value มลูคา่ซือ้หรอืเพิม่ (รวมคา่นายหนา้และ VAT) (บาท) Decimal(23,5) Y 11 Sale Unit จ านวนหน่วยขายหรอืลด (หน่วย) Decimal(23,5) 12
. In 2019, the Company acquired non performing debt, both secure and unsecure loan, amount 28,933 million Baht (contractual value) with investment of 3,368 million Baht which divided to be almost the
baht or 15.2 percent due to an increasing of cash and cash equivalent from issuing debenture and an increase of purchased account receivable which the company acquired during the 1st half of this year